Perceptive Advisors as of Sept. 30, 2022
Portfolio Holdings for Perceptive Advisors
Perceptive Advisors holds 116 positions in its portfolio as reported in the September 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Amicus Therapeutics (FOLD) | 8.3 | $286M | 27M | 10.44 | |
| Mirati Therapeutics | 5.6 | $195M | 2.8M | 69.84 | |
| Cerevel Therapeutics Hldng I (CERE) | 5.3 | $184M | 6.5M | 28.26 | |
| Global Blood Therapeutics In | 4.6 | $158M | 2.3M | 68.10 | |
| Amylyx Pharmaceuticals (AMLX) | 4.5 | $154M | 5.5M | 28.15 | |
| Lianbio Sponsored Ads (LIANY) | 3.3 | $115M | 58M | 2.00 | |
| Cincor Pharma | 3.1 | $109M | 3.3M | 32.82 | |
| Bellus Health Com New | 3.1 | $108M | 10M | 10.56 | |
| Crinetics Pharmaceuticals In (CRNX) | 3.0 | $105M | 5.3M | 19.64 | |
| Springworks Therapeutics (SWTX) | 2.9 | $99M | 3.5M | 28.53 | |
| Iovance Biotherapeutics (IOVA) | 2.8 | $98M | 10M | 9.58 | |
| Relmada Therapeutics (RLMD) | 2.6 | $88M | 2.4M | 37.02 | |
| Prometheus Biosciences | 2.5 | $87M | 1.5M | 59.01 | |
| Xenon Pharmaceuticals (XENE) | 2.2 | $77M | 2.1M | 36.10 | |
| Aldeyra Therapeutics (ALDX) | 1.8 | $61M | 11M | 5.34 | |
| Meiragtx Holdings (MGTX) | 1.7 | $59M | 7.0M | 8.41 | |
| Inhibrx | 1.5 | $52M | 2.9M | 17.95 | |
| Verona Pharma Sponsored Ads (VRNA) | 1.5 | $52M | 5.0M | 10.22 | |
| Cogent Biosciences (COGT) | 1.4 | $48M | 3.2M | 14.92 | |
| Arcellx Common Stock (ACLX) | 1.3 | $46M | 2.5M | 18.77 | |
| Travere Therapeutics Note 2.250% 3/0 (Principal) | 1.3 | $46M | 45M | 1.02 | |
| Lyra Therapeutics | 1.3 | $46M | 9.1M | 5.01 | |
| Albireo Pharma | 1.3 | $46M | 2.4M | 19.36 | |
| Female Health (VERU) | 1.3 | $45M | 3.9M | 11.52 | |
| Relay Therapeutics (RLAY) | 1.3 | $44M | 1.9M | 22.37 | |
| Seagen | 1.3 | $43M | 317k | 136.83 | |
| Rapt Therapeutics | 1.2 | $41M | 1.7M | 24.06 | |
| Vbi Vaccines Inc Cda Com New | 1.1 | $37M | 52M | 0.71 | |
| Treace Med Concepts (TMCI) | 1.0 | $35M | 1.6M | 22.07 | |
| Nuvalent Inc-a (NUVL) | 0.9 | $32M | 1.7M | 19.44 | |
| Establishment Labs Holdings Ord (ESTA) | 0.9 | $32M | 578k | 54.61 | |
| BioMarin Pharmaceutical (BMRN) | 0.8 | $29M | 337k | 84.77 | |
| Sarepta Therapeutics (SRPT) | 0.8 | $28M | 253k | 110.54 | |
| Edwards Lifesciences (EW) | 0.8 | $27M | 330k | 82.63 | |
| Zymeworks | 0.8 | $27M | 4.4M | 6.15 | |
| Adma Biologics (ADMA) | 0.8 | $27M | 11M | 2.43 | |
| Miragen Therapeutics (VRDN) | 0.7 | $25M | 1.2M | 20.51 | |
| Apellis Pharmaceuticals (APLS) | 0.7 | $25M | 366k | 68.30 | |
| Immatics SHS (IMTX) | 0.7 | $25M | 2.5M | 10.00 | |
| Caremax Com Cl A | 0.7 | $24M | 3.4M | 7.09 | |
| Tarsus Pharmaceuticals (TARS) | 0.6 | $22M | 1.3M | 17.12 | |
| Revance Therapeutics | 0.6 | $22M | 809k | 27.00 | |
| Madrigal Pharmaceuticals (MDGL) | 0.6 | $22M | 331k | 64.99 | |
| Nautilus Biotechnology (NAUT) | 0.6 | $19M | 9.1M | 2.12 | |
| Cytek Biosciences (CTKB) | 0.6 | $19M | 1.3M | 14.72 | |
| Outset Med | 0.5 | $19M | 1.2M | 15.93 | |
| Iveric Bio | 0.5 | $19M | 1.0M | 17.94 | |
| Harmony Biosciences Hldgs In (HRMY) | 0.5 | $18M | 412k | 44.29 | |
| Arcus Biosciences Incorporated (RCUS) | 0.5 | $17M | 667k | 26.16 | |
| Bridgebio Pharma (BBIO) | 0.5 | $17M | 1.7M | 9.94 | |
| CryoLife (AORT) | 0.5 | $17M | 1.2M | 13.84 | |
| Coherus Biosciences (CHRS) | 0.5 | $16M | 1.7M | 9.61 | |
| Verrica Pharmaceuticals | 0.4 | $15M | 5.0M | 2.92 | |
| Akero Therapeutics (AKRO) | 0.4 | $15M | 430k | 34.05 | |
| Concert Pharmaceuticals I equity | 0.4 | $14M | 2.2M | 6.70 | |
| Athira Pharma (ATHA) | 0.4 | $14M | 4.8M | 2.97 | |
| Prothena Corp SHS (PRTA) | 0.4 | $14M | 230k | 60.63 | |
| Dice Therapeutics | 0.4 | $14M | 687k | 20.28 | |
| Hillevax | 0.4 | $13M | 765k | 17.09 | |
| Rain Therapeutics | 0.4 | $12M | 2.5M | 4.88 | |
| Astria Therapeutics (ATXS) | 0.3 | $12M | 1.3M | 9.04 | |
| Axogen (AXGN) | 0.3 | $11M | 950k | 11.92 | |
| Procept Biorobotics Corp (PRCT) | 0.3 | $11M | 264k | 41.46 | |
| Neurocrine Biosciences (NBIX) | 0.3 | $11M | 100k | 106.21 | |
| Morphic Hldg (MORF) | 0.3 | $10M | 363k | 28.30 | |
| Chemocentryx | 0.3 | $10M | 193k | 51.66 | |
| Landos Biopharma | 0.3 | $9.7M | 15M | 0.65 | |
| Larimar Therapeutics (LRMR) | 0.3 | $9.2M | 2.9M | 3.20 | |
| Singular Genomics Systems In | 0.3 | $8.8M | 3.5M | 2.50 | |
| Rocket Pharmaceuticals (RCKT) | 0.2 | $8.0M | 500k | 15.96 | |
| Kronos Bio | 0.2 | $7.2M | 2.2M | 3.35 | |
| Isoplexis Corp | 0.2 | $7.0M | 4.1M | 1.72 | |
| Nevro (NVRO) | 0.2 | $7.0M | 150k | 46.60 | |
| C4 Therapeutics Com Stk (CCCC) | 0.2 | $6.7M | 766k | 8.77 | |
| Leap Therapeutics | 0.2 | $6.6M | 7.5M | 0.88 | |
| Solid Biosciences | 0.2 | $6.3M | 13M | 0.47 | |
| Revolution Medicines (RVMD) | 0.2 | $6.1M | 311k | 19.72 | |
| Aclaris Therapeutics (ACRS) | 0.2 | $5.4M | 341k | 15.74 | |
| Natera (NTRA) | 0.2 | $5.3M | 120k | 43.82 | |
| Tricida Put Option | 0.2 | $5.2M | 500k | 10.48 | |
| Inari Medical Ord | 0.1 | $5.1M | 70k | 72.64 | |
| Envveno Medical (NVNO) | 0.1 | $4.9M | 782k | 6.28 | |
| Sema4 Holdings Corp Com Cl A | 0.1 | $4.4M | 5.0M | 0.88 | |
| Somalogic Class A Com | 0.1 | $4.4M | 1.5M | 2.90 | |
| Tyra Biosciences (TYRA) | 0.1 | $4.3M | 494k | 8.79 | |
| Cti Biopharma | 0.1 | $4.3M | 735k | 5.82 | |
| Athenex | 0.1 | $4.2M | 16M | 0.27 | |
| Acumen Pharmaceuticals (ABOS) | 0.1 | $4.0M | 400k | 10.03 | |
| Point Biopharma Global | 0.1 | $3.9M | 500k | 7.73 | |
| Health Catalyst (HCAT) | 0.1 | $3.8M | 390k | 9.70 | |
| Nanobiotix Sponsored Ads (NBTX) | 0.1 | $3.8M | 1.1M | 3.54 | |
| Coherus Biosciences Note 1.500% 4/1 (Principal) | 0.1 | $3.6M | 4.5M | 0.80 | |
| Y Mabs Therapeutics | 0.1 | $3.1M | 212k | 14.42 | |
| Pyxis Oncology Common Stock (PYXS) | 0.1 | $3.0M | 1.5M | 1.97 | |
| Absci Corp (ABSI) | 0.1 | $2.8M | 894k | 3.13 | |
| Poseida Therapeutics I (PSTX) | 0.1 | $2.6M | 750k | 3.53 | |
| Clover Health Investments Com Cl A (CLOV) | 0.1 | $2.6M | 1.5M | 1.70 | |
| Reata Pharmaceuticals Cl A | 0.1 | $2.5M | 100k | 25.13 | |
| Quotient SHS | 0.1 | $2.4M | 16M | 0.15 | |
| Science 37 Holdings | 0.1 | $2.4M | 1.5M | 1.61 | |
| Fulcrum Therapeutics (FULC) | 0.1 | $2.4M | 294k | 8.09 | |
| Travere Therapeutics (TVTX) | 0.1 | $2.2M | 91k | 24.64 | |
| Pear Therapeutics | 0.1 | $1.8M | 901k | 2.04 | |
| Dariohealth Corp Com New (DRIO) | 0.0 | $1.5M | 328k | 4.63 | |
| Protara Therapeutics Com Stk (TARA) | 0.0 | $859k | 290k | 2.96 | |
| Hyperfine Com Cl A (HYPR) | 0.0 | $751k | 927k | 0.81 | |
| Sonendo (SONX) | 0.0 | $655k | 612k | 1.07 | |
| Provention Bio | 0.0 | $498k | 111k | 4.50 | |
| Icosavax | 0.0 | $296k | 94k | 3.16 | |
| Motus Gi Hldgs Com New | 0.0 | $221k | 90k | 2.45 | |
| Eqrx *w Exp 12/17/202 | 0.0 | $205k | 250k | 0.82 | |
| Agile Therapeutics Com New | 0.0 | $158k | 532k | 0.30 | |
| Caremax *w Exp 06/08/202 | 0.0 | $113k | 60k | 1.88 | |
| Neptune Wellness Solutions I Com New | 0.0 | $87k | 57k | 1.52 | |
| Surrozen *w Exp 08/01/203 (SRZNW) | 0.0 | $31k | 167k | 0.19 | |
| Surrozen | 0.0 | $12k | 6.0k | 1.99 |